{{Rsnum
|rsid=10982256
|Gene=DFNB31
|Chromosome=9
|position=114498554
|Orientation=plus
|GMAF=0.4008
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=DFNB31
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 24.8 | 46.0 | 29.2
| HCB | 19.7 | 49.6 | 30.7
| JPT | 15.9 | 56.6 | 27.4
| YRI | 96.6 | 3.4 | 0.0
| ASW | 64.9 | 33.3 | 1.8
| CHB | 19.7 | 49.6 | 30.7
| CHD | 18.3 | 48.6 | 33.0
| GIH | 20.8 | 54.5 | 24.8
| LWK | 98.2 | 1.8 | 0.0
| MEX | 48.3 | 41.4 | 10.3
| MKK | 76.1 | 22.6 | 1.3
| TSI | 19.6 | 46.1 | 34.3
| HapMapRevision=28
}}[[rs10982256]] has been reported in a large study to be associated with [[bipolar disorder]].

The risk allele (oriented to the dbSNP entry) is (T); the odds ratio associated with heterozygotes is 1.26 (CI 1.08-1.47), and for homozygotes, 1.47 (CI 1.24-1.74). {{PMID|17554300|OA=1
}}

{{PMID Auto GWAS
|PMID=21254220
|Trait=None
|Title=Propensity score-based nonparametric test revealing genetic variants underlying bipolar disorder.
|RiskAllele=
|Pval=0.000009
|OR=None
|ORtxt=None
|OA=1
}}

{{PMID Auto
|PMID=18421293
|Title=Meta-analysis of two genome-wide association studies of bipolar disorder reveals important points of agreement.
|OA=1
}}

{{PMID Auto
|PMID=19308021
|Title=Findings from bipolar disorder genome-wide association studies replicate in a Finnish bipolar family-cohort.
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}